Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Digi International
DGII
$3.23B
| $1.78M | ﹤0.01% |
84,550
+160
| +0.2% | +$3.31K |
|
2727
CRA International
CRAI
$1.07B
| $1.78M | ﹤0.01% |
17,877
+206
| +1% | +$18.6K |
|
2728
Uranium Energy
UEC
$5.54B
| $1.77M | ﹤0.01% |
580,532
+37,981
| +7% | +$95.2K |
|
|
IDEX
2729
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $1.76M | ﹤0.01% |
7,135
+206
| +3% | +$60K |
|
2730
United States Lime & Minerals
USLM
$3.37B
| $1.73M | ﹤0.01% |
71,675
+2,460
| +4% | +$68.5K |
|
2731
Cognyte Software
CGNT
$692M
| $1.73M | ﹤0.01% |
84,187
+3,630
| +5% | +$92.8K |
|
2732
Metropolitan Bank Holding Corp
MCB
$1.17B
| $1.73M | ﹤0.01% |
20,523
+988
| +5% | +$72K |
|
|
NESR
2733
National Energy Services Reunited Corp
NESR
$3.62B
| $1.73M | ﹤0.01% |
138,098
+19,530
| +16% | +$238K |
|
|
DFTX
2734
Definium Therapeutics
DFTX
$5.9B
| $1.72M | ﹤0.01% |
49,137
+3,617
| +8% | +$156K |
|
2735
Veritone
VERI
$139M
| $1.71M | ﹤0.01% |
71,626
+151
| +0.2% | +$3.08K |
|
2736
Boston Omaha
BOC
$431M
| $1.71M | ﹤0.01% |
44,115
+975
| +2% | +$32.2K |
|
2737
Rayonier Advanced Materials
RYAM
$570M
| $1.71M | ﹤0.01% |
228,177
-283,074
| -55% | -$1.95M |
|
2738
StoneCo
STNE
$2.49B
| $1.7M | ﹤0.01% |
49,074
+13,106
| +36% | +$680K |
|
|
ACRE
2739
Ares Commercial Real Estate
ACRE
$264M
| $1.7M | ﹤0.01% |
112,871
+16,439
| +17% | +$249K |
|
2740
Sight Sciences
SGHT
$458M
| $1.69M | ﹤0.01% |
+74,580
| New | +$2.45M |
|
2741
Genco Shipping & Trading
GNK
$1.13B
| $1.68M | ﹤0.01% |
83,286
+3,564
| +4% | +$66K |
|
2742
Curis
CRIS
$3.91M
| $1.67M | ﹤0.01% |
534
+6
| +1% | +$18.7K |
|
|
DADA
2743
DELISTED
Dada Nexus
DADA
| $1.67M | ﹤0.01% |
83,226
+1,755
| +2% | +$39.7K |
|
|
MCF
2744
DELISTED
Contango Oil & Gas Co.
MCF
| $1.66M | ﹤0.01% |
363,081
-254
| -0.1% | -$967 |
|
2745
Retractable Technologies
RVP
$20.3M
| $1.63M | ﹤0.01% |
147,368
| – | – |
|
2746
Sterling Infrastructure
STRL
$16.9B
| $1.6M | ﹤0.01% |
70,474
+58
| +0.1% | +$1.3K |
|
2747
HCI Group
HCI
$2.32B
| $1.6M | ﹤0.01% |
14,401
+39
| +0.3% | +$4.07K |
|
2748
Evolv Technologies
EVLV
$1.04B
| $1.57M | ﹤0.01% |
+261,971
| New | +$2.08M |
|
2749
Clarus
CLAR
$145M
| $1.57M | ﹤0.01% |
61,095
-72
| -0.1% | -$1.99K |
|
|
SNPO
2750
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
| $1.57M | ﹤0.01% |
+93,927
| New | +$1.75M |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.